| Literature DB >> 21612608 |
Kondethimmanahalli H Chandramouli1, Flora S Y Mok, Hao Wang, Pei-Yuan Qian.
Abstract
BACKGROUND: The metamorphosis of the spionid polychaete Pseudopolydora vexillosa includes spontaneous settlement onto soft-bottom habitats and morphogenesis that can be completed in a very short time. A previous study on the total changes to the proteome during the various developmental stages of P. vexillosa suggested that little or no de novo protein synthesis occurs during metamorphosis. In this study, we used multicolor fluorescence detection of proteins in 2-D gels for differential analysis of proteins and phosphoproteins to reveal the dynamics of post-translational modification proteins in this species. A combination of affinity chromatography, 2D-PAGE, and mass spectrometry was used to identify the phosphoproteins in pre-competent larvae, competent larvae, and newly metamorphosed juveniles.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21612608 PMCID: PMC3115903 DOI: 10.1186/1471-213X-11-31
Source DB: PubMed Journal: BMC Dev Biol ISSN: 1471-213X Impact factor: 1.978
Figure 1Developmental stages of the spionid . Three developmental stages were chosen for proteomic analysis: (A) pre-competent larvae, (B) competent larvae, and (C) newly metamorphosed juveniles.
Figure 2Representative phosphoproteome gels of . Pre: pre-competent larvae, Com: competent larvae, Juv: newly metamorphosed juveniles. (A) The protein extracts were separated on narrow-range IPG strips (pH/pI 4-7) followed by 12.5% 2-DE and stained with the phosphoprotein-specific stain ProQ Diamond. (B) Number of phosphoprotein spots reproducibly detected in the three developmental stages. (C) Number of up-regulated and down-regulated phosphoprotein spots (Student's t-test (p < 0.01, n = 3).
Figure 3Representative total proteome gels of . Pre: pre-competent larvae, Com: competent larvae, Juv: newly metamorphosed juveniles. (A) After 2-DE, the gels were stained with the total protein stain Sypro Ruby. (B) Number of protein spots reproducibly detected in the three developmental stages. (C) Number of up-regulated and down-regulated total protein spots. Differentially expressed spots showed a greater than two-fold change and a significant difference between stages (Student's t-test (p < 0.01, n = 3).
Figure 4Relative intensity and stage-specific phosphoproteins in successive developmental stages of . (A) Percentage of phosphorylated proteins, (B) overall relative intensity of the phosphoproteome, (C) number of stage-specific phosphoprotein spots, and (D) number of stage-specific total protein spots (Student's t-test (p < 0.01, n = 3).
Figure 5Close view of phosphoprotein spots (spots 1-11) differentially expressed (indicated by arrows) during metamorphosis in . (A): Enlarged phosphoprotein gels (Pre: pre-competent larvae, Com: competent larvae, Juv: juveniles). (B) Relative intensity of the differentially regulated phosphoproteins. (C) Phosphoprotein-to protein intensity ratios.
Figure 6Close view of phosphoprotein spots (spots 12-21) differentially expressed (indicated by arrows) during metamorphosis in . (A) Enlarged phosphoprotein gels (Pre: pre-competent larvae, Com: competent larvae, Juv: juveniles). (B) Relative intensity of the differentially regulated phosphoproteins. (C) Phosphoprotein-to-protein intensity ratios.
Figure 7Close view of phosphoprotein spots (spots 22-32) differentially expressed (indicated by arrows) during metamorphosis in . (A) Enlarged phosphoprotein gels (Pre: pre-competent larvae, Com: competent larvae, Juv: juveniles). (B) Relative intensity of the differentially regulated phosphoproteins. (C) Phosphoprotein-to-protein intensity ratios.
Identification of Differentially Expressed Proteins in P. vexillosa during Metamorphosis by MALDI-TOF MS
| PM/SC (%) | Phosphorylation variation ratios | Biological process | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PRE | COM | META | |||||||
| 1 | Contig08739_26/gi|224049395 | Enolase-phosphatase E1 | 230/13 | 3.7/4.2 | 13/47 | 1.78 | 9.25 | 0.19 | Amino-acid biosynthesis |
| 3 | GG70GXE04J1FKM_1/gi|198433617 | Glutaredoxin | 29/25 | 4.5/9.6 | 10/19 | 1.12 | 20.53 | 0.27 | Redox metabolism, oxidative stress |
| 5 | Contig06643_7/gi|126116628 | Paramyosin | 34/30 | 5.5/5.1 | 10/38 | 1.17 | 0.33 | 0.09 | Myofibril assembly, muscle contraction |
| 6 | gi|91085405 | GA20008-PA | 32/25 | 5.8/10 | 6/25 | 1.07 | 1.37 | 0.18 | RNA processing |
| 11 | GG7OGXE04JZMIN_9/gi|194214808 | Fatty acid binding protein 1, adipocyte | 30/20 | 6.0/8.2 | 10/44 | 1.01 | 10.05 | 0.11 | Energy storage, inflammation |
| 15 | GG70GXE04JCRO8_1/gi|37528876 | actin | 14/10 | 5.7/4.9 | 6/44 | 0.74 | 6.38 | 0.08 | Cellular structure |
| 27 | Contig00736_21/gi|189007782 | Myosin heavy chain | 66/100 | 5.6/5.1 | 18/15 | 2.09 | 47.30 | 0.20 | Myogenesis, muscle contraction |
| 28 | Contig00736_21/gi|189007782 | Myosin heavy chain | 63/109 | 5.1/5.8 | 8/14 | 0.82 | 2.05 | 0.16 | Myogenesis, muscle contraction |
| 29 | Contig02680_11/gi|4468655 | Intermediate Filament A | 60/57 | 5.5/5.3 | 9/26 | 0.12 | 9.27 | 0.25 | Structural integrity, cell motility |
| 32 | gi|182623856 | Beta actin | 18/25 | 5.6/5.3 | 7/34 | 1.07 | 3.32 | 0.69 | Cellular structure |
a) Accession numbers are from the NCBInr and in-house P. vexillosa transcriptomic databases. b) For positive identification, the score had to be over the significance threshold (p < 0.05). c) Observed (Obs.) MW and pI values were estimated from 2-DE gels and Theoretical (Theo.) MW and pI values were derived from a database search by MASCOT. PM: number of peptides matching the protein sequence; SC: sequence coverage.
Identification of abundant phosphoproteins in P. vexillosa during metamorphosis by MALDI-TOF MS.
| PM/SC (%) | Biological process | |||||
|---|---|---|---|---|---|---|
| 33 | Contig0667618/gi|291243919 | Nuclear ribonucleoprotein | 36/34 | 6.5/6.5 | 16/22 | rRNA processing |
| 34 | Contig56810076 | Beta-actin | 20/19 | 5.7/5.3 | 10/28 | Cellular structure protein |
| 35 | gi|149912747 | ABC transporter | 33/33 | 5.8/5.4 | 7/29 | Hormone response regulation |
| 36 | gi|116740271 | Alpha-tubulin | 43/43 | 6.9/5.9 | 10/18 | Cytokinesis, cell division |
| 37 | GG70GXE04JMNIB_2/gi|212449 | Myosin heavy chain | 60/15 | 6.6/5.0 | 03/44 | Myogenesis, muscle contraction |
| 38 | gi|131573157 | Alpha-tubulin | 35/45 | 6.5/5.7 | 7/25 | Cytokinesis, cell division |
| 39 | gi|161072 | Alpha-tubulin | 40/50 | 5.7/4.9 | 9/10 | Cytokinesis, cell division |
| 40 | GG70GXE04H5QQL_10/gi|116250948 | Conserved hypothetical protein | 40/16 | 5.5/5.6 | 4/25 | Structural reorganization |
| 41 | Contig04504_14/gi|4481960 | Polydom protein | 40/15 | 5.5/4.7 | 12/21 | Protein-protein interaction, adhesion |
| 42 | F5K2Q4C01CF4OT_4/gi|467215 | Actin beta | 50/41 | 5.4/5.5 | 11/33 | Cellular structure protein |
| 43 | GG70GXE04JCRO8_11/gi|37528876 | Actin | 50/41 | 4.3/5.5 | 11/43 | Cellular structure protein |
| 44 | Contig02678_14/gi|4468655 | Intermediate Filamant A | 70/71 | 5.6/5.5 | 16/20 | Structural integrity, cell motility |
| 45 | gi|169824521 | DNA primase | 50/69 | 6.0/6.2 | 9/17 | DNA replication |
| 46 | gi|161072 | Alpha-tubulin | 48/50 | 6.0/6.4 | 5/49 | Cytokinesis, cell division |
| 47 | gi|38047815 | Alpha Tub84B | 18/28 | 5.4/5.3 | 14/25 | Cytokinesis, cell division |
| 48 | gi|38047815 | Alpha Tub84B | 18/28 | 5.4/5.3 | 9/25 | Cytokinesis, cell division |
| 49 | Contig10935_1/gi|168761509 | Splicing factor 3A subunit 1 | 16/10 | 5.6/10 | 4/46 | mRNA processing, splicing |
| 50 | gi|131573157 | Alpha tubulin | 15/10 | 5.7/5.7 | 8/57 | Cytokinesis, cell division |
| 51 | gi|197129678 | Tubulin beta 2 | 6/26 | 4.5/4.4 | 4/21 | Cytokinesis, cell division |
| 52 | gi|999627 | Epsilon trypsin | 17/9 | 4.8/6.6 | 5/46 | Proteolysis |
| 53 | Contig06726_6/gi|148225538 | Tyrosine 3-monooxygenase | 35/30 | 4.5/4.7 | 4/26 | Muscle contraction |
| 54 | Contig13459_11/gi|4481960 | Low-density lipoprotein receptor | 33/22 | 4.5/4.6 | 11/31 | |
| 55 | gi|78190577 | Beta-tubulin | 55/43 | 5.3/5.7 | 11/37 | Cytokinesis, cell division |
| 56 | gi|159400261 | Alpha-tubulin | 60/47 | 5.3/5.2 | 5/18 | Cytokinesis, cell division |
| 57 | Contig56810076/gi|37528876 | Actin, cytoplasmic | 53/45 | 5.5/5.3 | 9/28 | Cellular structure protein |
| 58 | gi|178045 | Gamma-actin | 29/26 | 5.5/5.7 | 12/25 | Cellular structure protein |
| 59 | Contig56810077/gi|37528876 | Actin, cytoplasmic A3 | 32/45 | 5.7/5.5 | 7/18 | Cellular structure protein |
| 60 | gi|47117349 | Tropomyosin | 35/39 | 4.5/4.6 | 8/19 | Muscle degeneration and differentiation |
a) Accession numbers are from the NCBInr and in-house P. vexillosa transcriptomic databases. b) For positive identification, the score had to be over the significance threshold level (p < 0.05). c) Observed (Obs.) MW and pI values were estimated from 2-DE gels and Theoretical (Theo.) MW and pI values were derived from a database search by MASCOT. PM: number of peptides matching the protein sequence; SC: sequence coverage.
Figure 8Functional classification of the identified phosphoproteins. The differentially expressed proteins are shown in bold and underlined.
Figure 92-DE Western blot analysis during metamorphosis in . Two-dimensional gel and immunoblot of tubulin (A) and actin (B) of P.vexillosa (Precom: pre-competent larvae, Com: competent larvae, Juv: juveniles) probed with anti-tubulin and anti-actin monoclonal antibodies and developed by ECL western blotting analysis system.